Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells

A combined therapy of sulindac sulfide and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising strategy for the treatment of cancer. Sulindac sulfide had been shown to induce the expression of death receptor 5 (DR5), a receptor for TRAIL, and sensitize cancer cells to TRAI...

Descripción completa

Detalles Bibliográficos
Autores principales: Horinaka, Mano, Yoshida, Tatsushi, Tomosugi, Mitsuhiro, Yasuda, Shusuke, Sowa, Yoshihiro, Sakai, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126006/
https://www.ncbi.nlm.nih.gov/pubmed/25102912
http://dx.doi.org/10.1038/srep06000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126006/
https://www.ncbi.nlm.nih.gov/pubmed/25102912
http://dx.doi.org/10.1038/srep06000

Ejemplares similares